Abstract: Enhanced, specific nucleic acid targeting complexes comprising endo and exonuclease activity, and related methods that allow both targeted degradation of specific and/or non-specific nucleic acids in vivo and specific temporal regulation of nuclease activity to prevent off-target activity are disclosed herein. Through practice of the disclosure, nucleic acids, and cells harboring them, such as cancer cells or pathogens, are selectively degraded in vivo.
Type:
Grant
Filed:
September 25, 2020
Date of Patent:
November 8, 2022
Assignees:
GFLAS LIFE SCIENCES, INC., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Inventors:
Sungyong In, Sunghwa Choe, Mi Jin Park, Aiden Y. Park, Jung Hak Lim, Dong Wook Kim, Youngdong Yoo, Jongjin Park
Abstract: The present disclosure provides compositions and methods for increasing mutation efficiency and homologous recombination rates of site-specific endonucleases. The compositions and methods comprise a chimeric polypeptide comprising a site-specific endonuclease or a domain thereof and a functional moiety. The current inventions relate to functional enhancement of the CRISPR-Cas enzymes. Disclosed herein include possible variants and their intended improvements.
Type:
Grant
Filed:
December 21, 2018
Date of Patent:
April 5, 2022
Assignees:
GFLAS LIFE SCIENCES, INC., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Inventors:
Jongjin Park, Ji Young Yoon, Sunmee Choi, Mijin Park, Slki Park, Aiden Y. Park, Jung Hyuk Lee, Junghak Lim, Dong Wook Kim, Sunghwa Choe